UncategorizedWhy Citius Pharmaceuticals (CTXR) Stock Is Down 15% Sumain Faisal2 weeks ago01 mins Citius Pharmaceuticals shares are trading lower by 15% during Wednesday’s session. The company announced a $3 million registered direct offering. read more Post navigation Previous: Oil Price Drop To Cut Exxon Mobil’s Q4 Upstream Earnings By Up To $0.9 Billion: DetailsNext: Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Trump’s EV Rollback Might Shake-Up ETFs: Winners, Losers And Tesla’s Unique Role In Shifting Market Sumain Faisal1 hour ago 0
Procter & Gamble Q2 Earnings Preview: Can Strong Report Bring Consumer Staples Stocks Back To Life? Sumain Faisal1 hour ago 0
Johnson & Johnson Q4 Earnings Loom As FDA Approves Depression Drug: Will Long-Term Weakness Reverse? Sumain Faisal1 hour ago 0